ZimVie

ZimVie Inc. is a global life sciences leader operating within the dental market. Established in March 2022 as an independent, publicly traded company spun off from Zimmer Biomet, ZimVie was created to bring a dedicated strategic focus to its comprehensive portfolio of trusted dental and spine products. While initially encompassing both dental and spine divisions, the company has since divested its spine business to concentrate exclusively on the dental sector. Headquartered in Palm Beach Gardens, Florida, ZimVie develops, manufactures, and distributes an extensive range of products and solutions designed to support dental tooth replacement and restoration procedures. The company's mission is centered on improving smiles, function, and confidence in daily life for patients worldwide. It serves a diverse customer base that includes oral surgeons, dental specialists, general dentists, and dental laboratories across more than 70 countries.

The company's product portfolio is built on a legacy of innovation and clinical excellence. Key offerings include advanced dental implant systems like the T3 PRO and TSX implants, which are recognized for their proprietary surface technologies that promote long-term bone health. In addition to implants, ZimVie provides a suite of biomaterials, including bone grafts and collagen wound care products. A significant part of ZimVie's strategy involves advancing digital dentistry. The company offers a complete digital workflow, featuring solutions such as the RealGUIDE® software suite for guided surgery, Implant Concierge® services for treatment planning, and the Encode® Impression System, which simplifies the process from scanning to final restoration. Through its commitment to research, development, and professional education via the ZimVie Institute, the company partners with clinicians to advance dental technology and enhance patient outcomes. In July 2025, ZimVie entered into a definitive agreement to be acquired by the private equity firm ARCHIMED, positioning the company for its next phase of growth as a private entity.